Abstract

Carpaine has long been identified as the major alkaloid in Carica papaya leaves that possess muscle relaxant properties. Limited study on the molecular signaling properties of carpaine urges us to conduct this study that aims to elucidate the mechanism underlying the cardioprotective effect of carpaine in embryonic cardiomyocytes of the H9c2 cell line. The 50% inhibitory concentration (IC50) of carpaine was first determined using a colorimetric MTT assay to establish the minimum inhibitory concentration for the subsequent test. Using a 1 µM carpaine treatment, a significant increase in the H9c2 proliferation rate was observed following 24 and 48 h of incubation. A Western blot analysis also revealed that carpaine promotes the upregulation of the cell cycle marker proteins cyclin D1 and PCNA. Carpaine-induced H9c2 cell proliferation is mediated by the activation of the FAK-ERK1/2 and FAK-AKT signaling pathways. In the setting of ischemia-reperfusion injury (IRI), carpaine provided a significant protective role to recover the wounded area affected by the hydrogen peroxide (H2O2) treatment. Furthermore, the oxidative-stress-induced reduction in mitochondrial membrane potential (MMP) and overproduction of reactive oxygen species (ROS) were attenuated by carpaine treatment. The current study revealed a novel therapeutic potential of carpaine in promoting in vitro cardiomyocyte proliferation and repair following injury.

Highlights

  • During embryonic and fetal heart development, cardiomyocytes undergo high-rate proliferation to form mature heart chambers to accommodate the high demand of the systemic circulation [1]

  • We investigated carpaine-induced cell proliferation using embryonic cardiomyocytes of the H9c2 cell line

  • We demonstrated that treatment with 1 μM carpaine significantly increased the H9c2 cell proliferation rate after 24 (p < 0.001) and 48 h (p < 0.01) of incubation (Figure 1b)

Read more

Summary

Introduction

During embryonic and fetal heart development, cardiomyocytes undergo high-rate proliferation to form mature heart chambers to accommodate the high demand of the systemic circulation [1]. The proliferation rate gradually declines during the postnatal stage, where cardiomyocytes stop dividing and switch to hypertrophic growth when exposed to an increased workload [2]. The recovery process of the adult heart after IRI is limited, due to the terminally differentiated and rarely dividing characteristic of the adult cardiomyocytes. This limitation makes it challenging to regenerate and replace the damaged and dead cardiomyocytes. There is no curative treatment to induce cardiomyocyte regeneration after injury

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call